21 March 2022 • 1 minute read
The moral imperative: Balancing innovation, regulation and prescription drug availability
In this episode, DLA Piper's Jim Greenwood and Geoff Levitt are joined by Peter Kolchinsky, founding Partner and Portfolio Manager at RA Capital, to discuss the importance of – and complications in - balancing biopharmaceutical innovation, industry regulations and prescription drug availability.
